Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2026-09-14 16:10:38 ET · period of report 2026-09-11 · accession 0001628280-26-061836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-14 16:10 | 2026-09-11 | AMRX | BUCHI J KEVIN | Dir | M - OptEx | $14.45 | +20.4K | 95.5K | +27% | +$295.4K |
| D | 2026-09-14 16:10 | 2026-09-11 | AMRX | BUCHI J KEVIN | Dir | M - OptEx | $0.00 | -20.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-11 | M | A | 20,445 | $14.45 | 95,522 | D | — | — | |
| 2 | Derivative | Stock Option | 2026-09-11 | M | D | 20,445 | $0.00 | 0 | D | $14.45 · — to 2026-11-23 | 20,445 Class A Common Stock | (F1) The option is vested and currently exercisable. |